Bo Jiang

4.2k total citations
188 papers, 2.9k citations indexed

About

Bo Jiang is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bo Jiang has authored 188 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Surgery, 49 papers in Oncology and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bo Jiang's work include Gastric Cancer Management and Outcomes (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). Bo Jiang is often cited by papers focused on Gastric Cancer Management and Outcomes (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). Bo Jiang collaborates with scholars based in China, United States and Hong Kong. Bo Jiang's co-authors include Wei Gong, Fachao Zhi, William E. Theurkauf, Yang Bai, Heike von Baum, Pieter C. Wensink, Wansheng Chen, Side Liu, Xinying Wang and Xiaowei Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Bo Jiang

177 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Jiang China 28 879 832 775 722 371 188 2.9k
Nobuaki Yagi Japan 31 609 0.7× 739 0.9× 1.2k 1.5× 1.2k 1.6× 404 1.1× 139 2.7k
Fabio Cianchi Italy 34 1.1k 1.3× 1.3k 1.5× 1.2k 1.6× 627 0.9× 295 0.8× 153 3.9k
Robert Sitarz Poland 17 1.2k 1.4× 944 1.1× 855 1.1× 987 1.4× 140 0.4× 46 3.3k
Shigemi Matsumoto Japan 26 866 1.0× 1.6k 2.0× 557 0.7× 636 0.9× 99 0.3× 136 3.2k
M. Anti Italy 28 1.0k 1.1× 944 1.1× 895 1.2× 340 0.5× 342 0.9× 65 3.1k
Minhua Zheng China 31 1.4k 1.6× 1.1k 1.3× 853 1.1× 944 1.3× 240 0.6× 148 3.2k
Tomoki Makino Japan 37 640 0.7× 1.3k 1.6× 2.2k 2.9× 1.8k 2.5× 378 1.0× 269 3.9k
Pengfei Yu China 27 1.2k 1.3× 726 0.9× 795 1.0× 436 0.6× 91 0.2× 137 2.9k
Hirokazu Taniguchi Japan 30 1.4k 1.6× 1.1k 1.3× 565 0.7× 553 0.8× 203 0.5× 140 3.4k
Toshio Takahashi Japan 32 834 0.9× 828 1.0× 878 1.1× 886 1.2× 267 0.7× 144 3.3k

Countries citing papers authored by Bo Jiang

Since Specialization
Citations

This map shows the geographic impact of Bo Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Jiang more than expected).

Fields of papers citing papers by Bo Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Jiang. The network helps show where Bo Jiang may publish in the future.

Co-authorship network of co-authors of Bo Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Jiang. A scholar is included among the top collaborators of Bo Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Jiang. Bo Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Bo, Honglong Ning, Rihui Yao, et al.. (2025). Predictive modeling of electrochromic performance in ammonium metatungstate solutions using machine learning algorithms. AIP Advances. 15(2). 1 indexed citations
2.
Jiang, Bo, et al.. (2025). Morphine exacerbates myocardial ischemia/reperfusion injury by overactivation of NLRP3 inflammasome via suppression of p-TRPV1 in male rats. European Journal of Pharmacology. 1000. 177736–177736. 1 indexed citations
3.
Zhang, Han, et al.. (2025). Emission inventory development for spatiotemporal release of vanadium from anthropogenic sources in China. Atmospheric chemistry and physics. 25(11). 5577–5589. 1 indexed citations
5.
Zhang, Lifeng, et al.. (2025). The ACSL family: Bridging fatty acid metabolism and cell death in cancer progression. Metabolism. 176. 156470–156470.
6.
Jiang, Bo, et al.. (2025). Bifurcation of Periodic Gait and Chaos in a Bipedal Model with Asymmetric Leg Motion. International Journal of Bifurcation and Chaos. 35(5). 1 indexed citations
7.
Shao, Rong, Bo Jiang, Yin Hu, et al.. (2024). Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers. Basic & Clinical Pharmacology & Toxicology. 135(6). 743–754. 4 indexed citations
8.
Jiang, Bo, Ying Guo, Ming‐Yu Yang, et al.. (2024). The analgesic effect of continuous adductor canal block combined with popliteal plexus block for total knee arthroplasty: a randomized controlled trial. Scientific Reports. 14(1). 27757–27757. 3 indexed citations
9.
Wang, Chun, et al.. (2023). Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease. BMC Pulmonary Medicine. 23(1). 299–299. 1 indexed citations
10.
Yang, Dandan, Xiaodan Wang, Yichao Xu, et al.. (2023). Bioequivalence Study of Epalrestat for Healthy Chinese Subjects. Clinical Pharmacology in Drug Development. 13(5). 485–490. 2 indexed citations
11.
Xu, Jing‐Yuan, et al.. (2023). UPLC-QTOF-MS/MS and Bioinformatics Association Analysis Reveals the Pharmacodynamic Flavonoids in Scutellaria barbata and the Underlying Anti-Colorectal Cancer Mechanism. American journal of biochemistry & biotechnology. 19(4). 298–320. 1 indexed citations
12.
Ma, Jia, et al.. (2021). Ultrasound Guidance Is Not Superior in Subacromial Bursa and Intraarticular Injections but Superior in Bicipital Groove: A Meta-analysis of Randomized Controlled Trials. Arthroscopy The Journal of Arthroscopic and Related Surgery. 38(5). 1642–1657. 3 indexed citations
13.
Duan, Xiaohui, Yi Cai, Tingting He, et al.. (2021). The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds. Journal of Gastrointestinal Oncology. 12(4). 1786–1796. 11 indexed citations
14.
Chen, Jinliang, Yichao Xu, Honggang Lou, et al.. (2020). Effect of Genetic Polymorphisms on the Pharmacokinetics of Deferasirox in Healthy Chinese Subjects and an Artificial Neural Networks Model for Pharmacokinetic Prediction. European Journal of Drug Metabolism and Pharmacokinetics. 45(6). 761–770. 8 indexed citations
15.
Zhang, Xiangqi, Junjun Chen, Xiao Xiao, et al.. (2020). Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules. Journal of Ethnopharmacology. 261. 113067–113067. 21 indexed citations
16.
Zhou, Jieqiong, Xiaowei Tang, Jing Wang, et al.. (2017). Feasibility of a novel low-volume and sodium phosphate-free bowel preparation regimen for colon capsule endoscopy. Experimental and Therapeutic Medicine. 14(2). 1739–1743. 6 indexed citations
17.
Cai, Jianqun, et al.. (2013). Esophageal variceal bleeding caused by posterior mediastinal Castleman's disease. Gastrointestinal Endoscopy. 77(4). 658–659. 1 indexed citations
18.
Jiang, Bo, et al.. (2011). Induction of cytochrome P450 3A by Shexiang Baoxin Pill and its main components. Chemico-Biological Interactions. 195(2). 105–113. 19 indexed citations
20.
Zhi, Fachao, et al.. (2010). Diagnosis and prognosis of 280 patients with pancreatic carcinoma. 10(1). 2–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026